BTHE Stock | News | Quote | Stock Forum | Wednesday, October

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Boston Therapeutics Inc BTHE Company Overview 

Boston Therapeutics Inc BTHE Current Price and Quotes
Last Price 1.25
Previous Close 1.25 Open 1.25
Daily Range 1.25 - 1.25 52wk Range 1.65 - 0.15
Volume 2,500 Dividend N/A
Average Vol (3m) 20,199 Yield N/A

BTHE Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt1=Go!

Last Updated: Wednesday, October 30, 2013 02:35:33 AM

Boston Therapeutics Inc BTHE

Company Verified Profile
Company Information

1750 Elm Street
Manchester, NH 03104

Website: http://www.bostonti.com
Phone: 603-935-9799
Email: info@bostonti.com

Boston Therapeutics Inc BTHE
Boston Therapeutics, headquartered in Manchester, NH, (OTCQB: BTHE) is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: PAZ320, a non-systemic chewable compound designed to reduce post-meal glucose elevation, and IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia associated with diabetes. More information is avai...



Boston Therapeutics Inc BTHE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001473579
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 26, 2012
Incorporated In: DE, USA
Year of Inc. 2009
Employees Not Available
Company Officers/Contacts

David Platt CEO, CFO
Anthony Squeglia CFO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Mcgladrey & Pullen LLP (MA)
80 City Square
Boston, MA, 02129
United States

Legal Counsel
Seyfarth Shaw LLP
Two Seaport Lane
Boston, MA, 02210
United States

Investor Relations Firm
DGI Investor Relations, Inc.
75 Maiden Lane
New York, NY, 10038
United States


Boston Therapeutics Inc BTHE
BTHE Security Details

Share Structure

Market Value1 $24,229,424 a/o Oct 29, 2013
Shares Outstanding 19,383,539 a/o Jul 23, 2013
Float 2,309,118 a/o May 18, 2012
Authorized Shares 100,000,000 a/o Sep 30, 2011
Par Value  0.001
Shareholders

Shareholders of Record 1,678 a/o Apr 04, 2013
Short Selling Data

Short Interest 0 (-100%)
May 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Worldwide Stock Transfer, LLC

Boston Therapeutics Inc BTHE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 42 4 -
Cost of Revenue 57 6 -
Gross Profit (15) (2) -
Operating Expenses

Research and Development 179 194 11
Sales, General and Admin. 1,269 615 230
Non-Recurring Items - - -
Other - - -
Operating Income (1,463) (812) (241)
Income From Continuing Operations

Add'l Income/Expense Items (3) - -
Earnings Before Interest and Tax (1,466) (812) (241)
Interest Expense 18 16 7
Earnings Before Tax (1,484) (827) (248)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,484) (827) (248)
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,484) (827) (248)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,484) (827) (248)

Boston Therapeutics Inc BTHE Recent News

Oct 16, 2013 Boston Therapeutics to Present at the Livingston Securities Advanced and Nano Life Sciences Summit
Oct 15, 2013 Boston Therapeutics Initiates Research Study on PAZ320 at University of Minnesota
Oct 7, 2013 Systemic Versus Non-Systemic Diabetes Drugs
Oct 7, 2013 Helping People with Diabetes Block the Bad Carbs
Oct 3, 2013 Boston Therapeutics Closes $5.3 Million in Private Placement of Common Stock and Warrants
Sep 9, 2013 Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants
Sep 4, 2013 Boston Therapeutics Reports Positive Phase II Results of PAZ320 Are Published in July/August Issue of Endocrine Practice
Aug 9, 2013 Boston Therapeutics Reports Financial Results and Corporate Update for the Second Quarter and Six Months Ended June 30, 2013
Aug 2, 2013 Boston Therapeutics to Exhibit at 2013 American Association of Diabetes Educators Annual Meeting & Exhibition in Philadelphia


BTHE Boston Therapeutics Inc Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BTHE/quote
Stock Chart http://www.otcmarkets.com/stock/BTHE/chart
Company Info http://www.otcmarkets.com/stock/BTHE/company-info
Recent News http://www.otcmarkets.com/stock/BTHE/news
Financials http://www.otcmarkets.com/stock/BTHE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BTHE/filings
Short Sales http://www.otcmarkets.com/stock/BTHE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BTHE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BTHE/research
Summary http://finance.yahoo.com/q?s=BTHE
Historical Prices http://finance.yahoo.com/q/hp?s=BTHE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BTHE
Basic Chart http://finance.yahoo.com/q/bc?s=BTHE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BTHE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BTHE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BTHE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BTHE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BTHE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BTHE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BTHE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BTHE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BTHE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BTHE
Balance Sheet http://finance.yahoo.com/q/bs?s=BTHE
Cash Flow http://finance.yahoo.com/q/cf?s=BTHE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BTHE
Market Watch http://www.marketwatch.com/investing/stock/BTHE
Bloomberg http://www.bloomberg.com/quote/BTHE:US
Morningstar http://quotes.morningstar.com/stock/s?t=BTHE
Bussinessweek http://investing.businessweek.com/research/st...icker=BTHE
Barchart http://www.barchart.com/quotes/stocks/BTHE
OTC Short Report http://otcshortreport.com/index.php?index=BTHE
Investopedia http://www.investopedia.com/markets/stocks/BTHE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 6

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 4

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 4

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Retirement Security Faces Global Headwinds in 2026

Updated Category News Views 10

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

Continue Reading
Miguel Pantoja: Wiring a Second Chance Beyond Bars

Updated Category News Views 5

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 4

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 5

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading
BeyondCPG Accelerator Launches Seventh Growth Program

Updated Category News Views 4

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 5

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 5

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading

Top 5 Most Recently Viewed Articles

Nano Hearing Aids' CEO Global Tour: Strengthening Connections Worldwide

Updated Category News Views 58

Nano Hearing Aids' Global Strategy: A Tour to Remember Nano Hearing Aids is taking significant strides in expanding its presence worldwide. As part of this vision, Ryan F. Zackon, the esteemed CEO, is setting out on an ambitious global tour. This initiative aims to deepen partnerships and solidify relationships within the hearing aid community. Tour Objectives: Fostering...

Continue Reading
Toll Brothers Stock: A Look at 15 Years of Growth

Updated Category News Views 141

The Impressive Journey of Toll Brothers Stock Toll Brothers (NYSE: TOL) has demonstrated remarkable resilience and growth over the past 15 years. With an average annual return of 14.07%, it has outperformed the market by 1.87%. As of now, the company's market capitalization stands at an impressive $12.22 billion. Investment Potential: What If You Bought $1,000? Imagine...

Continue Reading
DigiKey Showcases Automation Innovations at SPS 2025 Event

Updated Category News Views 198

DigiKey to Showcase Automation Innovations at SPS 2025 Global distributor highlights extensive range of industrial automation products available in Europe THIEF RIVER FALLS, Minn. — DigiKey, a renowned global distributor of electronic components and automation solutions, invites attendees of the Smart Production Solutions (SPS) conference to visit its booth, #106 in...

Continue Reading
Cocrystal Pharma Advances CDI-988 in Phase 1 Clinical Trials

Updated Category News Views 120

Exciting Progress for CDI-988 in Clinical Trials Cocrystal Pharma, Inc. (NASDAQ: COCP) recently shared encouraging findings from its Phase 1 study of CDI-988, an innovative pan-viral inhibitor, during the Military Health System Research Symposium. This multi-day event focused on advancing military medical care, with Cocrystal presenting influential data that showcases the...

Continue Reading
Increased Support for Nova Minerals' Estelle Project Advancements

Updated Category News Views 153

Introduction to the Estelle Project Nova Minerals Limited (NASDAQ: NVA) has recently reported significant support for its Estelle Gold and Critical Minerals Project from Alaska State government officials and representatives from the Australian Consulate. These interactions highlight the growing recognition of the Estelle Project as crucial for the development of both...

Continue Reading